ANDREW JAMES GASE

Allopathic & Osteopathic Physicians|Family Medicine TIFFIN, OH NPI 1760475909

General Payments — all program years on this page

$500.77

  • Category: General Payments
  • Program years: PY2019–2023
  • Record count: 31
  • As of (CMS publication): 2026-01-23

Latest program year (PY2023): $333.90 across 20 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2023) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $314.2819
Education $19.621

By paying entity

Latest program year (PY2023) · sorted by reported total.

By program year

Program yearAmountRecords
2019 $14.701
2022 $152.1710
2023 $333.9020

Records — PY2023 (20)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1000052231 Bayer Healthcare Pharmaceuticals Inc. $12.73 07/31/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1000061793 Bayer Healthcare Pharmaceuticals Inc. $13.50 11/28/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1000133190 Bayer Healthcare Pharmaceuticals Inc. $19.62 05/01/2023 Education Undisputed 01/23/2026 View at CMS
1000190811 Bayer Healthcare Pharmaceuticals Inc. $28.77 05/15/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1002154203 Novo Nordisk Inc $14.82 08/16/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1002253817 GlaxoSmithKline, LLC. $18.02 07/12/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1012486653 NESTLE HEALTHCARE NUTRITION INC. $13.95 09/25/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1014840947 AstraZeneca Pharmaceuticals LP $20.19 10/25/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1015753517 AstraZeneca Pharmaceuticals LP $17.61 04/12/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1021340605 Seqirus USA Inc $21.23 12/20/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1028684545 bioMerieux Inc $13.87 11/01/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1031234885 Lilly USA, LLC $14.17 08/23/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1031249691 Lilly USA, LLC $14.60 10/02/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1031257005 Lilly USA, LLC $15.60 12/26/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1048734133 Merck Sharp & Dohme LLC $16.22 06/06/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1050534523 PFIZER INC. $12.85 01/31/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1056264835 MannKind Corporation $14.27 09/26/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
997322905 ABBVIE INC. $16.19 08/10/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
997322907 ABBVIE INC. $17.42 12/05/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
997322909 ABBVIE INC. $18.27 12/14/2023 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.